Smad2 Mouse shRNA Plasmid (Locus ID 17126)
CAT#: TR509694
Smad2 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (1)
Specifications
Product Data | |
Product Name | Smad2 Mouse shRNA Plasmid (Locus ID 17126) |
Locus ID | 17126 |
UniProt ID | Q62432 |
Synonyms | 7120426M23Rik; Madh2; Madr2; mMad2; Smad-2 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | Smad2 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 17126). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | BC021342, BC089184, NM_001252481, NM_001311070, NM_010754, NM_010754.1, NM_010754.2, NM_010754.3, NM_010754.4, NM_001252481.1, BC058713, BM248478 |
Summary | Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. May act as a tumor suppressor in colorectal carcinoma. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator (By similarity).[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Suppression of canonical TGF-β signaling enables GATA4 to interact with H3K27me3 demethylase JMJD3 to promote cardiomyogenesis
,Riching, AS;Danis, E;Zhao, Y;Cao, Y;Chi, C;Bagchi, RA;Klein, BJ;Xu, H;Kutateladze, TG;McKinsey, TA;Buttrick, PM;Song, K;,
Journal of molecular and cellular cardiology
,PubMed ID 33359755
[SMAD2]
|
Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification
,null,
Cell Death and Differentiation
,PubMed ID 28800128
[Smad2]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...